4.1 Article

EM703, a new derivative of erythromycin, inhibits transforming growth factor-beta signaling in human lung fibroblasts

Journal

EXPERIMENTAL LUNG RESEARCH
Volume 34, Issue 6, Pages 343-354

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/01902140802093238

Keywords

EM703; fibroblast; IPF; macrolides; Smad; TGF-beta

Ask authors/readers for more resources

Long-term, low-dose macrolide therapy has been proven to improve survival in patients with diffuse panbronchiolitis and cystic fibrosis, although the mechanisms by which it does so remain unknown. To elucidate the molecular mechanisms of the anti-inflammatory effects of macrolides, the authors examined the effects of erythromycin (EM-A) and new derivative EM703 on transforming growth factor (TGF)-beta/Smad signaling fibroblasts. EM-A and EM703 each inhibited fibroblast proliferation and the collagen production in human lung fibroblasts induced by TGF-beta. EM-A and EM703 inhibited the augmentation of Smad3 mRNA induced by TGF-beta. Smad7 mRNA was inhibited by TGF-beta, but augmented by coincubation with EM-A or EM703. EM-A and EM703 each inhibited p-Smad2/3 proteins induced by TGF-beta. Smad7 protein inhibited by TGF-beta restored beyond basal level by EM-A and EM703. These findings suggest that EM-A and EM703 inhibit TGF-beta signaling in human lung fibroblasts via inhibition of p-Smad2/3 through recovery of Smad7 level.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Polymer Science

Extemporaneous Preparation of Injectable and Enzymatically Degradable 3D Cell Culture Matrices from an Animal-Component-Free Recombinant Protein Based on Human Collagen Type I

Hiroyuki Kamata, Satoko Ashikari-Hada, Yusuke Mori, Akihiko Azuma, Ken-ichiro Hata

MACROMOLECULAR RAPID COMMUNICATIONS (2019)

Article Medicine, General & Internal

Severe Pneumonitis with Alveolar Hemorrhage Associated with Herbal Medicines: A Case Report

Miwako Omori, Yoshinobu Saito, Yukiko Miura, Toru Tanaka, Takeru Kashiwada, Kenichiro Atsumi, Hiroki Hayashi, Yuji Minegishi, Kazue Fujita, Arata Azuma, Masahiro Seike, Akihiko Gemma

JOURNAL OF NIPPON MEDICAL SCHOOL (2019)

Article Genetics & Heredity

Primary ciliary dyskinesia caused by a large homozygous deletion including exons 1-4 of DRC1 in Japanese patients with recurrent sinopulmonary infection

Naoto Keicho, Minako Hijikata, Kozo Morimoto, Sakae Homma, Yoshio Taguchi, Arata Azuma, Shoji Kudoh

MOLECULAR GENETICS & GENOMIC MEDICINE (2020)

Article Critical Care Medicine

Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis A Randomized, Double-Blind Placebo-controlled Trial

Yasuhiro Kondoh, Arata Azuma, Yoshikazu Inoue, Takashi Ogura, Susumu Sakamoto, Kenji Tsushima, Takeshi Johkoh, Kiminori Fujimoto, Kazuya Ichikado, Yasuo Matsuzawa, Takefumi Saito, Kazuma Kishi, Keisuke Tomii, Noriho Sakamoto, Masahiro Aoshima, Jun Araya, Shinyu Izumi, Machiko Arita, Mitsuhiro Abe, Hiroyoshi Yamauchi, Joe Shindoh, Takafumi Suda, Masaki Okamoto, Masahito Ebina, Yoshihito Yamada, Yuji Tohda, Tetsuji Kawamura, Yoshio Taguchi, Hiroshi Ishii, Naozumi Hashimoto, Shinji Abe, Hiroyuki Taniguchi, Jun Tagawa, Koji Bessho, Natsuki Yamamori, Sakae Homma

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Review Rheumatology

Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease

Masataka Kuwana, Arata Azuma

MODERN RHEUMATOLOGY (2020)

Letter Critical Care Medicine

Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial Reply

Yasuhiro Kondoh, Arata Azuma, Jun Tagawa, Sakae Homma

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Letter Critical Care Medicine

Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis Reply

Yasuhiro Kondoh, Arata Azuma, Jun Tagawa, Natsuki Yamamori, Sakae Homma

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Letter Critical Care Medicine

When the Game Changes Guidance to Adjust Sarcoidosis Management During the Coronavirus Disease 2019 Pandemic

Nadera J. Sweiss, Peter Korsten, Huzaefah J. Syed, Aamer Syed, Robert P. Baughman, Arthur M. F. Yee, Daniel A. Culver, Teresa Sosenko, Arata Azuma, Francesco Bonella, Ulrich Costabel, Wonder P. Drake, Marjolein Drent, Elyse E. Lower, Dominique Israel-Biet, Remy L. M. Mostard, Hilario Nunes, Paola Rottoli, Paolo Spagnolo, Athol U. Wells, Wim A. Wuyts, Marc A. Judson

CHEST (2020)

Article Cardiac & Cardiovascular Systems

Prevalence of atrial FDG uptake and associationwith atrial arrhythmias in patients with cardiac sarcoidosis

Kenji Yodogawa, Yoshimitsu Fukushima, Takahiro Ando, Yu-ki Iwasaki, Kazuyoshi Akiyama, Shin-ichiro Kumita, Arata Azuma, Yoshihiko Seino, Wataru Shimizu

INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)

Article Rheumatology

Nintedanib in patients with systemic sclerosis-associated interstitial lung disease: A Japanese population analysis of the SENSCIS trial

Masataka Kuwana, Takashi Ogura, Shigeki Makino, Sakae Homma, Yasuhiro Kondoh, Aiko Saito, Hiroyuki Ugai, Martina Gahlemann, Kazuhiko Takehara, Arata Azuma

Summary: Nintedanib demonstrated efficacy in Japanese patients with SSc-ILD, showing a slower decline in FVC compared to placebo over 52 weeks. There was no heterogeneity detected in treatment effect between Japanese and non-Japanese patients, and the safety profile of nintedanib in Japanese patients was similar to that in patients with idiopathic pulmonary fibrosis.

MODERN RHEUMATOLOGY (2021)

Editorial Material Respiratory System

Efforts to control air pollution in the Asia-Pacific region

Yasuo Morimoto, Hena Khatun, Kwok Sang Wilson Yee, Agus Dwi Susanto, Jun-Pyo Myong, Joven Jeremius Tanchuco, Chau-Chyun Sheu, Ngo Quy Chau, Arata Azuma

RESPIROLOGY (2020)

Article Rheumatology

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

James R. Seibold, Toby M. Maher, Kristin B. Highland, Shervin Assassi, Arata Azuma, Laura Kathleen Hummers, Ulrich Costabel, Ute von Wangenheim, Veronika Kohlbrenner, Martina Gahlemann, Margarida Alves, Oliver Distler

ANNALS OF THE RHEUMATIC DISEASES (2020)

Article Medicine, General & Internal

Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo

Naoyuki Kuse, Koichiro Kamio, Arata Azuma, Kuniko Matsuda, Minoru Inomata, Jiro Usuki, Akemi Morinaga, Toru Tanaka, Takeru Kashiwada, Kenichiro Atsumi, Hiroki Hayashi, Yoshinobu Saito, Masahiro Seike, Akihiko Gemma

JOURNAL OF NIPPON MEDICAL SCHOOL (2020)

Review Respiratory System

New Era of Management Concept on Pulmonary Fibrosis with Revisiting Framework of Interstitial Lung Diseases

Arata Azuma, Luca Richeldi

TUBERCULOSIS AND RESPIRATORY DISEASES (2020)

Article Respiratory System

Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan

Yuji Minegishi, Akihiko Gemma, Sakae Homma, Kazuma Kishi, Arata Azuma, Takashi Ogura, Naoki Hamada, Hiroyuki Taniguchi, Noboru Hattori, Yasuhiko Nishioka, Kiminobu Tanizawa, Takeshi Johkoh, Takuma Yokoyama, Kazutaka Mori, Yoshio Taguchi, Masahito Ebina, Naohiko Inase, Koichi Hagiwara, Hiroshi Ohnishi, Hiroshi Mukae, Yoshikazu Inoue, Kazuyoshi Kuwano, Hirofumi Chiba, Ken Ohta, Yoshinori Tanino, Fumikazu Sakai, Yukihiko Sugiyama

ERJ OPEN RESEARCH (2020)

No Data Available